Standard BioTools Inc. Property, Plant and Equipment, Gross
Standard BioTools Inc. (LAB) had Property, Plant and Equipment, Gross of $65.47 million as of 2026-06-30, per its 10-Q filed 2026-08-05.
Financial Statements › Balance Sheet › Assets › Assets, Noncurrent › Property, Plant, and Equipment, after Accumulated Depreciation, Depletion, and Amortization › Property, Plant, and Equipment, before Accumulated Depreciation, Depletion, and Amortization
us-gaap:PropertyPlantAndEquipmentGross · last filed 2026-08-05
- 2026-06-30: Property, Plant and Equipment, Gross $65.47M.
- 2026-03-31: Property, Plant and Equipment, Gross $65.31M.
- 2025-12-31: Property, Plant and Equipment, Gross $66.54M.
- 2025-09-30: Property, Plant and Equipment, Gross $67.44M.
| Period end | Property, Plant and Equipment, Gross | Property, Plant and Equipment, Gross as first filed |
|---|---|---|
| 2026-06-30 | $65.47M 10-Q · filed 2026-08-05 | |
| 2026-03-31 | $65.31M 10-Q · filed 2026-05-06 | |
| 2025-12-31 | $66.54M 10-Q · filed 2026-08-05 | |
| 2025-09-30 | $67.44M 10-Q · filed 2025-11-04 | |
| 2025-06-30 | $67.19M 10-Q · filed 2025-08-15 | |
| 2025-03-31 | $113.66M 10-Q · filed 2025-05-06 | |
| 2024-12-31 | $57.01M 10-K · filed 2026-03-16 | $106.34M 10-K · filed 2025-03-11 |
| 2024-09-30 | $105.38M 10-Q · filed 2024-11-06 | |
| 2024-06-30 | $103.79M 10-Q · filed 2024-08-06 | |
| 2024-03-31 | $102.80M 10-Q · filed 2024-05-09 | |
| 2023-12-31 | $57.34M 10-K · filed 2025-03-11 | |
| 2023-09-30 | $55.13M 10-Q · filed 2023-11-07 | |
| 2023-06-30 | $54.27M 10-Q · filed 2023-08-08 | |
| 2023-03-31 | $54.04M 10-Q · filed 2023-05-09 | |
| 2022-12-31 | $53.07M 10-K · filed 2024-03-01 | |
| 2022-09-30 | $53.28M 10-Q · filed 2022-11-09 | |
| 2022-06-30 | $53.86M 10-Q · filed 2022-08-09 | |
| 2022-03-31 | $54.19M 10-Q · filed 2022-05-09 | |
| 2021-12-31 | $50.19M 10-K · filed 2023-03-14 | |
| 2021-09-30 | $32.59M 10-Q · filed 2021-11-09 | |
| 2021-06-30 | $32.53M 10-Q · filed 2021-08-06 | |
| 2021-03-31 | $31.85M 10-Q · filed 2021-05-07 | |
| 2020-12-31 | $31.54M 10-K · filed 2022-03-08 | |
| 2020-09-30 | $33.68M 10-Q · filed 2020-11-09 | |
| 2020-06-30 | $34.07M 10-Q · filed 2020-08-07 | |
| 2020-03-31 | $33.40M 10-Q · filed 2020-05-11 | |
| 2019-12-31 | $32.93M 10-K · filed 2021-02-25 | |
| 2018-12-31 | $31.66M 10-K · filed 2020-02-27 | |
| 2017-12-31 | $33.94M 10-K · filed 2019-03-18 | |
| 2016-12-31 | $40.00M 10-K · filed 2018-03-08 | |
| 2015-12-31 | $34.29M 10-K · filed 2017-03-03 | |
| 2014-12-31 | $28.29M 10-K · filed 2016-02-29 | |
| 2013-12-31 | $19.01M 10-K · filed 2015-02-26 | |
| 2012-12-31 | $16.79M 10-K · filed 2014-03-12 | |
| 2011-12-31 | $13.88M 10-K · filed 2013-03-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ROCKET PHARMACEUTICALS, INC. (RCKT) | United States | $0.296B | -21.78 |
| Vanda Pharmaceuticals Inc. (VNDA) | United States | $0.302B | -1.35 |
| Fulcrum Therapeutics, Inc. (FULC) | United States | $0.289B | -3.28 |
| Contineum Therapeutics, Inc. (CTNM) | United States | $0.289B | -4.40 |
| GT Biopharma, Inc. (GTBP) | United States | $0.309B | -4.58 |
| Perspective Therapeutics, Inc. (CATX) | United States | $0.284B | -3.34 |
| Upstream Bio, Inc. (UPB) | United States | $0.284B | -2.42 |
| ABEONA THERAPEUTICS INC. (ABEO) | United States | $0.312B | -5.63 |
| Sagimet Biosciences Inc. (SGMT) | United States | $0.279B | |
| Prelude Therapeutics Inc (PRLD) | United States | $0.318B | -7.01 |